human alpha1-proteinase inhibitor

Poland

Drugs containing this active substance

  • RYMPHYSIA

    The medicine is used in adults with severe alpha1-proteinase inhibitor deficiency who have developed emphysema. It helps protect lung tissue and slows the progression of the disease, although it does not reverse existing damage.

    Form: powder and solvent for preparation of concentrate for infusion solution

    Active substance Dosage
    human alpha1-proteinase inhibitor 500 mg

    ATC: B02AB02

    Manufacturer: Takeda Manufacturing Austria AG

  • The medicine is used in adults with diagnosed severe alpha1-proteinase inhibitor deficiency who have developed emphysema. It helps protect lung tissue and slows the progression of the disease.

    Form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    human alpha1-proteinase inhibitor 1000 mg

    ATC: B02AB02

    Manufacturer: Takeda Manufacturing Austria AG